pyrazinamide has been researched along with Leprosy, Borderline in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Leprosy, Borderline: A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levy, L | 1 |
1 other study available for pyrazinamide and Leprosy, Borderline
| Article | Year |
|---|---|
Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report.
Topics: Animals; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Mice; Pyrazin | 1988 |